scientist researcher factor1
Top Stories

STUDY WILL TEST SURVIVORS’ BLOOD TO TREAT EBOLA

Published by Gbaf News

Posted on November 21, 2014

1 min read
Add as preferred source on Google

MARILYNN MARCHIONE,AP Chief Medical Writer

Ebola Blood Plasma Treatment Study

A group of donors led by the Bill & Melinda Gates Foundation will provide experimental drugs and fund a study to collect blood plasma from Ebola survivors to treat new victims of the disease in West Africa.

How Plasma May Help Battle Ebola

Plasma contains antibodies, substances the immune system makes to fight the virus. Several Ebola patients have received plasma from survivors and recovered, but doctors say there is no way to know whether it works without a rigorous study.

Funding and Collaborators for the Study

The Gates Foundation is giving $5.7 million for the project in West Africa. More than a dozen companies, universities and others are contributing supplies, staff and cash, and are working with the countries and the World Health Organization on specific procedures and locations.

The plans were announced Tuesday.

Key Takeaways

  • The Gates Foundation is funding a study to test convalescent plasma from Ebola survivors for treating the virus.
  • The effort includes $5.7 million in funding and partnerships with private firms, universities, WHO, and affected countries.
  • Mobile units and pathogen-inactivation technology are employed to safely collect and use plasma.
  • The trial’s focus is evaluating the safety and efficacy of survivor plasma and experimental drugs like brincidofovir.

References

Frequently Asked Questions

Who is funding the study?
The Bill & Melinda Gates Foundation is providing $5.7 million in funding.
What treatment is being tested?
Researchers are testing convalescent plasma from Ebola survivors and experimental drugs like brincidofovir.
Where will it take place?
Trials will be conducted in Guinea and other Ebola‑affected West African countries in coordination with national authorities and WHO.
How is donor plasma collected safely?
Using mobile plasmapheresis units equipped with pathogen‑inactivation systems such as Cerus INTERCEPT.

Tags

Related Articles

More from Top Stories

Explore more articles in the Top Stories category